OpenURL Connection Search

Select item for more details and to access through your institution.

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
Published in:
Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03860-w
By:
- Galvagno, Federica;
- Leuci, Valeria;
- Massa, Annamaria;
- Donini, Chiara;
- Rotolo, Ramona;
- Capellero, Sonia;
- Proment, Alessia;
- Vitali, Letizia;
- Lombardi, Andrea Maria;
- Tuninetti, Valentina;
- D'Ambrosio, Lorenzo;
- Merlini, Alessandra;
- Vigna, Elisa;
- Valabrega, Giorgio;
- Primo, Luca;
- Puliafito, Alberto;
- Sangiolo, Dario
Publication type:
Article
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810368
By:
- Fiorino, Erika;
- Merlini, Alessandra;
- D'Ambrosio, Lorenzo;
- Cerviere, Ilaria;
- Berrino, Enrico;
- Marchiò, Caterina;
- Giraudo, Lidia;
- Basiricò, Marco;
- Massa, Annamaria;
- Donini, Chiara;
- Leuci, Valeria;
- Rotolo, Ramona;
- Galvagno, Federica;
- Vitali, Letizia;
- Proment, Alessia;
- Ferrone, Soldano;
- Pisacane, Alberto;
- Pignochino, Ymera;
- Aglietta, Massimo;
- Grignani, Giovanni
Publication type:
Article
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers.
Published in:
British Journal of Haematology, 2023, v. 200, n. 1, p. 64, doi. 10.1111/bjh.18469
By:
- Circosta, Paola;
- Donini, Chiara;
- Gallo, Susanna;
- Giraudo, Lidia;
- Gammaitoni, Loretta;
- Rotolo, Ramona;
- Galvagno, Federica;
- Capellero, Sonia;
- Basiricò, Marco;
- Casucci, Monica;
- Aglietta, Massimo;
- Ferrero, Ivana;
- Fagioli, Franca;
- Cignetti, Alessandro;
- Carnevale‐Schianca, Fabrizio;
- Leuci, Valeria;
- Sangiolo, Dario
Publication type:
Article
Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models.
Published in:
Molecular Oncology, 2024, v. 18, n. 6, p. 1552, doi. 10.1002/1878-0261.13595
By:
- Maione, Federica;
- Oddo, Daniele;
- Galvagno, Federica;
- Falcomatà, Chiara;
- Pandini, Marta;
- Macagno, Marco;
- Pessei, Valeria;
- Barault, Ludovic;
- Gigliotti, Chiara;
- Mira, Alessia;
- Corti, Giorgio;
- Lamba, Simona;
- Riganti, Chiara;
- Castella, Barbara;
- Massaia, Massimo;
- Rad, Roland;
- Saur, Dieter;
- Bardelli, Alberto;
- Di Nicolantonio, Federica
Publication type:
Article
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Published in:
Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102628
By:
- Vitali, Letizia;
- Merlini, Alessandra;
- Galvagno, Federica;
- Proment, Alessia;
- Sangiolo, Dario
Publication type:
Article

Found: 5

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers.

Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models.

Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.